165 related articles for article (PubMed ID: 24209894)
41. Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotaemic rat.
Felsenfeld AJ; Machado L; Bover J; Trinidad P; Rodriguez M
Nephrol Dial Transplant; 1993; 8(4):325-34. PubMed ID: 8390007
[TBL] [Abstract][Full Text] [Related]
42. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy.
Massry SG; Popovtzer MM; Coburn JW; Makoff DL; Maxwell MH; Kleeman CR
N Engl J Med; 1968 Sep; 279(13):697-700. PubMed ID: 5670911
[No Abstract] [Full Text] [Related]
43. Gabapentin: a promising drug for the treatment of uremic pruritus.
Naini AE; Harandi AA; Khanbabapour S; Shahidi S; Seirafiyan S; Mohseni M
Saudi J Kidney Dis Transpl; 2007 Sep; 18(3):378-81. PubMed ID: 17679749
[TBL] [Abstract][Full Text] [Related]
44. Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
Kokuho T; Toya Y; Kawaguchi Y; Tamura K; Iwatsubo K; Dobashi Y; Nakazawa A; Takeda H; Iwatsubo M; Hirawa N; Yasuda G; Ohnishi T; Umemura S
Ther Apher Dial; 2007 Dec; 11(6):442-8. PubMed ID: 18028171
[TBL] [Abstract][Full Text] [Related]
45. Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate.
Khajehdehi P; Taheri S
J Ren Nutr; 2003 Apr; 13(2):78-83. PubMed ID: 12671829
[TBL] [Abstract][Full Text] [Related]
46. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
47. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.
Gravesen E; Hofman-Bang J; Lewin E; Olgaard K
Scand J Clin Lab Invest; 2013 Mar; 73(2):107-16. PubMed ID: 23281842
[TBL] [Abstract][Full Text] [Related]
48. Can calcium, phosphate, calcium phosphate product and intact parathyroid hormone levels be appropriately controlled in dialysis patients?
Deger SM; Mutluay R; Derici U; Mandiralioglu F; Arinsoy T; Sindel S
Med Princ Pract; 2011; 20(1):85-9. PubMed ID: 21160221
[TBL] [Abstract][Full Text] [Related]
49. Uremic pruritus is associated with higher kt/V and serum calcium concentration.
Duque MI; Thevarajah S; Chan YH; Tuttle AB; Freedman BI; Yosipovitch G
Clin Nephrol; 2006 Sep; 66(3):184-91. PubMed ID: 16995341
[TBL] [Abstract][Full Text] [Related]
50. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus.
Mathur VS; Kumar J; Crawford PW; Hait H; Sciascia T;
Am J Nephrol; 2017; 46(6):450-458. PubMed ID: 29253847
[TBL] [Abstract][Full Text] [Related]
51. Substance P and intensity of pruritus in hemodialysis and peritoneal dialysis patients.
Snit M; Gawlik R; Łącka-Gaździk B; Kuźniewicz R; Dwornicki M; Owczarek A; Walaszczyk M; Grabiec P; Grzeszczak W
Med Sci Monit; 2013 Sep; 19():723-32. PubMed ID: 23995243
[TBL] [Abstract][Full Text] [Related]
52. Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uraemic pruritus.
Ståhle-Bäckdahl M; Hägermark O; Lins LE; Törring O; Hilliges M; Johansson O
J Intern Med; 1989 Jun; 225(6):411-5. PubMed ID: 2746157
[TBL] [Abstract][Full Text] [Related]
53. Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study.
Tagawa M; Hamano T; Nishi H; Tsuchida K; Hanafusa N; Fukatsu A; Iseki K; Tsubakihara Y
PLoS One; 2014; 9(12):e114678. PubMed ID: 25494334
[TBL] [Abstract][Full Text] [Related]
54. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study.
Pauli-Magnus C; Mikus G; Alscher DM; Kirschner T; Nagel W; Gugeler N; Risler T; Berger ED; Kuhlmann U; Mettang T
J Am Soc Nephrol; 2000 Mar; 11(3):514-519. PubMed ID: 10703675
[TBL] [Abstract][Full Text] [Related]
55. Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream.
Tarng DC; Cho YL; Liu HN; Huang TP
Nephron; 1996; 72(4):617-22. PubMed ID: 8730431
[TBL] [Abstract][Full Text] [Related]
56. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits.
Hamada J; Tamai K; Ono W; Saotome K
J Rheumatol; 2006 Jan; 33(1):119-26. PubMed ID: 16395759
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the efficacy and safety of zinc sulfate vs. placebo in the treatment of pruritus of hemodialytic patients: a pilot randomized, triple-blind study.
Mapar MA; Pazyar N; Siahpoosh A; Latifi SM; Beladi Mousavi SS; Khazanee A
G Ital Dermatol Venereol; 2015 Aug; 150(4):351-5. PubMed ID: 24825404
[TBL] [Abstract][Full Text] [Related]
58. HbA1c is related with uremic pruritus in diabetic and nondiabetic hemodialysis patients.
Afsar B; Elsurer Afsar R
Ren Fail; 2012; 34(10):1264-9. PubMed ID: 21370992
[TBL] [Abstract][Full Text] [Related]
59. Metabolomic analysis of uremic pruritus in patients on hemodialysis.
Bolanos CG; Pham NM; Mair RD; Meyer TW; Sirich TL
PLoS One; 2021; 16(2):e0246765. PubMed ID: 33577623
[TBL] [Abstract][Full Text] [Related]
60. Pruritus in patients on maintenance hemodialysis.
Ståhle-Bäckdahl M; Hägermark O; Lins LE
Acta Med Scand; 1988; 224(1):55-60. PubMed ID: 3414408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
